Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: A retrospective computerized screening study

Drugs and Aging

Volumn 28, Issue 3, 2011, Pages 219-225

  Lin, Chen Fang ^a,b   Wang, Chun Yu ^a   Bai, Chyi Huey ^a,c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Drug utilisation; Elderly; Prescribing

Indexed keywords

PRESCRIPTION DRUG;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CHILD; DRUG INTERACTION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; OUTPATIENT; POLYPHARMACY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TAIWAN; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CHILD; CHILD, PRESCHOOL; COMPUTATIONAL BIOLOGY; DRUG INTERACTIONS; FEMALE; HEALTH SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OUTPATIENTS; POLYPHARMACY; RETROSPECTIVE STUDIES; TAIWAN; YOUNG ADULT;

EID: 79951929592     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11586870-000000000-00000     Document Type: Article

References (32)

1. von Euler M, Eliasson E, Ohlén G, et al. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf 2006; 15 (3): 179-84
2. Salazar JA, Poon I, Nair M. Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf 2007; 6 (6): 695-704 (Pubitemid 351308281)
3. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5 (4): 345-51
4. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005; 17 (4): 123-32
5. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005; 31 (9): 4-11
6. Zarowitz BJ, Stebelsky LA, Muma BK, et al. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005; 25 (11): 1636-45 (Pubitemid 41566922)
7. Brager R, Sloand E. The spectrum of polypharmacy. Nurse Pract 2005; 30 (6): 44-50
8. Faries D, Ascher-Svanum H, Zhu B, et al. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry 2005; 5: 26
9. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007; 370 (9582): 185-91 (Pubitemid 47042897)
10. Hohl CM, Dankoff J, Colacone A, et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 2001; 38 (6): 666-71 (Pubitemid 33131567)
11. Bjorkman IK, Fastbom J, Schmidt IK, et al. Drug-drug interactions in the elderly. Ann Pharmacother 2002; 36 (11): 1675-81 (Pubitemid 35265600)
12. Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother 2006; 4 (2): 134-43 (Pubitemid 44069476)
13. Fux R, Greiner D, Geldmacher M, et al. Multiple drug prescribing by general practitioners in a German region: implications for drug interactions and patient safety. Int J Clin Pharmacol Ther 2006; 44 (11): 539-47 (Pubitemid 44718189)
14. Janchawee B, Wongpoowarak W, Owatranporn T, et al. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther 2005; 30 (1): 13-20 (Pubitemid 41602088)
15. Merlo J, Liedholm H, Lindblad U, et al. Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ 2001; 323 (7310): 427-8
16. Solberg LI, Hurley JS, Roberts MH, et al. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data. Am J Manag Care 2004; 10 (11 Pt 1): 753-9 (Pubitemid 39518521)
17. Finkers F, Maring JG, Boersma F, et al. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther 2007; 32 (5): 469-76 (Pubitemid 47404286)
18. Viktil KK, Blix HS, Moger TA, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63 (2): 187-95 (Pubitemid 46072105)
19. Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 2006; 61 (5): 511-5 (Pubitemid 43794712)
20. Kohler GI, Bode-Böger SM, Busse R, et al. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000; 38 (11): 504-13
21. Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci 2006; 9 (3): 427-33 (Pubitemid 46630111)
22. Tulner LR, Kuper IM, Frankfort SV, et al. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions. Am J Geriatr Pharmacother 2009; 7 (2): 93-104
23. Nobili A, Pasina L, Tettamanti M, et al. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther 2009; 34 (4): 377-86
24. Cooney D, Pascuzzi K. Polypharmacy in the elderly: focus on drug interactions and adherence in hypertension. Clin Geriatr Med 2009; 25 (2): 221-33
25. Tulner LR, Frankfort SV, Gijsen GJ, et al. Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance. Drugs Aging 2008; 25 (4): 343-55 (Pubitemid 351440452)
26. Hosia-Randell HM, Muurinen SM, Pitkala KH. Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging 2008; 25 (8): 683-92
27. Becker ML, Visser LE, van Gelder T, et al. Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged ≥55 years. Drugs Aging 2008; 25 (2): 145-52
28. Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007; 30 (10): 911-8 (Pubitemid 47481446)
29. Haider SI, Johnell K, Thorslund M, et al. Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002. Int J Clin Pharmacol Ther 2007; 45 (12): 643-53
30. Straubhaar B, Krahenbuhl S, Schlienger RG. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Drug Saf 2006; 29 (1): 79-90 (Pubitemid 43213897)
31. Egger SS, Ratz Bravo AE, Hess L, et al. Age-related differences in the prevalence of potential drug-drug interactions in ambulatory dyslipidaemic patients treated with statins. Drugs Aging 2007; 24 (5): 429-40 (Pubitemid 46795183)
32. Thomson Micromedex. DRUG-REAX® system [online]. Available from URL: http://www.thomsonhc.com/home/dis-patch [Accessed 2002 Apr 30]